Interview: Aurélien Chaufour – Managing Director, Anjac, France
Aurélien Chaufour reveals how Anjac Health and Beauty has developed with a focus on innovation and industrial know-how since its creation in 2008 and how he today has four companies…
Created in 2008, Anjac Health and Beauty consists of four experts and complementary companies in the areas of health, hygiene, beauty. Anjac is much more than a manufacturer who formulates, manufactures and packages products for companies in the areas of health, beauty and hygiene. Their added value is an ability to imagine and develop innovative customized solutions that make a difference to clients.
Today Anjac has four companies that are expert in the fields of health, hygiene and beauty. First, Shadeline, dynamic company specializing in dermatology and cosmetics. Second, Euro Wipes, a major player in the wipes market, offering a full range of wipes and impregnated cotton pads. Third, Sicaf, a well-established partner of luxury cosmetic brands, known for its expertise in formulation, manufacturing and custom packaging. And lastly, Chemineau, a European specialist in contract development and manufacturing of pharmaceutical products, cosmetics and medical devices. In total they have five manufacturing and R&D facilities. Each year more than a thousand formulations and five thousand products are conceived, manufactured and packaged in their five sites.
Contact
15, rue de la Banque,
75002, PARIS
T : +33 1 53 45 94 49
F : +33 1 53 45 94 59
Aurélien Chaufour reveals how Anjac Health and Beauty has developed with a focus on innovation and industrial know-how since its creation in 2008 and how he today has four companies…
Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you speak to the importance of…
Endotis was incorporated in 2003 on the basis of a technology transfer from on a French public research institution. Can you elaborate on the origins? The group was founded from…
This interview was conducted with Jacques de Chilly and Theirry de Lumley of Aderly hereafter referred to as J.C. and T.L. respectively. Aderly was founded in 1974 in order to…
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club Inter-pharmaceutique (CIP) is a professional association created in…
As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall?…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always have had the feelings…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the…
See our Cookie Privacy Policy Here
